Related Experiment Video

Updated: Aug 25, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

The heart in systemic sclerosis

Virginia Steen1

  • 1Georgetown University, 3800 Reservoir Road, LL Gorman, Washington, DC 20007, USA. steenv@georgetown.edu

Current Rheumatology Reports
|March 16, 2004
PubMed

Insights

Scleroderma frequently causes heart problems, including asymptomatic cardiac abnormalities and diastolic dysfunction. Early detection and management are crucial for these serious heart complications.

Area of Science:

  • Cardiology
  • Rheumatology
  • Internal Medicine

Background:

  • Scleroderma significantly impacts the heart, leading to myocardial, conduction, and pericardial diseases.
  • Secondary cardiac dysfunction arises from scleroderma renal crisis and pulmonary hypertension.
  • Understanding scleroderma's cardiac manifestations is critical for patient outcomes.

Purpose of the Study:

  • To summarize recent advancements in understanding cardiac abnormalities in scleroderma.
  • To explore the mechanisms behind heart issues in scleroderma patients.
  • To highlight the role of new cardiac technologies in detecting these abnormalities.

Main Methods:

  • Review of recent literature on scleroderma and cardiac involvement.
  • Analysis of findings from new cardiac imaging and diagnostic technologies.
  • Evaluation of studies on diastolic dysfunction and conduction abnormalities.

Main Results:

  • New cardiac technologies reveal frequent asymptomatic cardiac abnormalities in scleroderma.
  • Diastolic dysfunction is increasingly recognized as common in scleroderma.
  • Conduction abnormalities and arrhythmias are significant, life-threatening complications.

Conclusions:

  • Scleroderma frequently affects the heart, often asymptomatically.
  • Further long-term studies are needed to guide treatment strategies.
  • Advanced diagnostics and therapies are improving management of cardiac complications.

More Related Videos

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...